Skip to content
Jennifer N. Serventi, PAC, BS

Jennifer N. Serventi, PAC, BS

Neurology

UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Accepting New Patients

Contact

About Me

Jennifer Serventi has been a neuro oncology physician assistant and research associate since 1998 and has been at the University of Rochester since 2007, with a faculty position as a physician assistant and senior research associate. There she has worked to build the largest clinical and research br...
Jennifer Serventi has been a neuro oncology physician assistant and research associate since 1998 and has been at the University of Rochester since 2007, with a faculty position as a physician assistant and senior research associate. There she has worked to build the largest clinical and research brain tumor program in the state outside of the metro NY area. In addition to managing the day-to-day care of around 100 new primary brain tumor patients each year, she has been focusing on telemedicine initiatives. In May 2016, Jennifer earned her Master’s degree in Leadership in Healthcare Systems at the University of Rochester School of Nursing. For her final project, she designed the Neuro-Oncology Connect Telemedicine Program, through which she and her team provide expert brain tumor treatment and access to clinical trials for patients throughout rural New York State. She is currently developing a regional remote tumor board and is looking for ways to increase access to clinical trials through the use of telehealth platforms.

Jennifer spends a large portion of her time in research activities. Throughout her career, Jennifer has facilitated and coordinated over 50 clinical trials associated with brain tumor treatment. She has a passion for teaching patients and other medical providers about the advancements made in the treatment of this rare disease and hopes someday to see a cure. She lives in Webster, NY with her husband and four sons.

Certified Specialties

Physician Assistant - National Commission on Certification of Physician Assistants

Faculty Appointments

Senior Associate - Department of Neurology, Neuro-Oncology (SMD)

Credentials

Education

PA-C | Wagner College. Physician Assistant. 1998

Awards

Adding Candles, Inc. Inaugural Luminary Award. 2016

Michele Unger Leadership Award. 2015

Publications

Journal Articles

Treatment-Related Decisions in Malignant Gliomas: A Feasibility Study.

Occhiogrosso J, Hemminger L, Burke J, Ibegbu C, Serventi J, Mohile N

Journal of palliative medicine.. 2020 February 23 (2):264-267. Epub 07/30/2019.

Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma.

Lacouture ME, Anadkat MJ, Ballo MT, Iwamoto F, Jeyapalan SA, La Rocca RV, Schwartz M, Serventi JN, Glas M

Frontiers in oncology.. 2020 10 :1045. Epub 07/28/2020.

Epilepsy education in gliomas: engaging patients and caregivers to improve care.

Wasilewski A, Serventi J, Ibegbu C, Wychowski T, Burke J, Mohile N

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.. 2019 July 2 Epub 07/02/2019.

Wireless transcutaneous electrical nerve stimulation device for chemotherapy-induced peripheral neuropathy: an open-label feasibility study.

Gewandter JS, Chaudari J, Ibegbu C, Kitt R, Serventi J, Burke J, Culakova E, Kolb N, Sluka KA, Tejani MA, Mohile NA

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.. 2019 May 27 (5):1765-1774. Epub 08/27/2018.

Surgery and Evidence-based Treatments in Patients with Newly Diagnosed High-grade Glioma.

Serventi J, Behr J

Seminars in oncology nursing.. 2018 December 34 (5):443-453. Epub 11/05/2018.

Acute care in glioblastoma: the burden and the consequences.

Wasilewski A, Serventi J, Kamalyan L, Wychowski T, Mohile N

Neuro-oncology practice.. 2017 December 4 (4):248-254. Epub 03/08/2017.

Palliative and end-of-life care in glioblastoma: defining and measuring opportunities to improve care.

Hemminger LE, Pittman CA, Korones DN, Serventi JN, Ladwig S, Holloway RG, Mohile NA

Neuro-oncology practice.. 2017 September 4 (3):182-188. Epub 09/27/2016.

Monitoring the effects of BCNU chemotherapy Wafers (Gliadel) in glioblastoma multiforme with proton magnetic resonance spectroscopic imaging at 3.0 Tesla.

Dyke JP, Sanelli PC, Voss HU, Serventi JV, Stieg PE, Schwartz TH, Ballon D, Shungu DC, Pannullo SC

Journal of neuro-oncology.. 2007 March 82 (1):103-10. Epub 09/22/2006.

Monitoring the Effects of BCNU Chemotherapy Wafers (Gliadel®) in Glioblastoma Multiforme with Proton Magnetic Resonance Spectroscopic Imaging at 3.0 Tesla

Jonathan P. Dyke, PhD; Pina C. Sanelli, MD; Henning U. Voss, PhD; Jennifer N. Serventi, R-PAC; Philip E. Stieg, PhD, MD; Theodore H. Schwartz, MD, Douglas Ballon, PhD; Dikoma C. Shungu, PhD; Susan C. Pannullo, MD.

Neuro-Oncology. 2006; .

A Phase I/II Study of a Twice-Daily Regimen of Temozolomide and Celecoxib for the Treatment of Relapsed/Refractory High-Grade Astrocytoma

SC Pannullo; J Burton; J Serventi; PE Stieg; S Hariharan; R Elsoueidi; I El-Jassous; C Balmaceda.

Neuro-Oncology. 2006; .